跳到正文

Parkman Healthcare Partners LLC 13F 持仓 · 2026年Q2

Parkman Healthcare Partners 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 76 只证券,申报市值合计 9.77 亿美元。前几大持仓:MBX(4.52%)、LLY(4.30%)、CVS(4.15%)。本季前 25 大持仓中:新建仓 2 只、增持 12 只、减持 11 只。

排名代码公司市值占组合股数变动
1MBXMBX BIOSCIENCES INC$44.2M4.52%800,173增持
2LLYELI LILLY & CO$42.0M4.30%35,000增持
3CVSCVS HEALTH CORP$40.5M4.15%391,791增持
4DXCMDEXCOM INC$36.0M3.69%534,767减持
5PTCTPTC THERAPEUTICS INC$35.5M3.64%435,691增持
6RCUSARCUS BIOSCIENCES INC$28.3M2.90%919,266减持
7GPCRSTRUCTURE THERAPEUTICS INC$26.1M2.67%485,661增持
8VRDNVIRIDIAN THERAPEUTICS INC$25.3M2.59%1.4M增持
9AGIOAGIOS PHARMACEUTICALS INC$24.8M2.54%669,046增持
10INBXINHIBRX BIOSCIENCES INC$24.3M2.49%256,950新建仓
11XENEXENON PHARMACEUTICALS INC$24.0M2.46%397,379减持
12EWTXEDGEWISE THERAPEUTICS INC$23.4M2.40%577,036增持
13UNHUNITEDHEALTH GROUP INC$23.2M2.38%55,921新建仓
14SYKSTRYKER CORPORATION$21.4M2.19%67,973减持
15IQVIQVIA HLDGS INC$20.4M2.09%105,811增持
16PODDINSULET CORP$20.0M2.05%131,378减持
17ZBHZIMMER BIOMET HOLDINGS INC$20.0M2.05%232,557减持
18ASMBASSEMBLY BIOSCIENCES INC$19.8M2.03%721,181增持
19SNDXSYNDAX PHARMACEUTICALS INC$19.2M1.96%877,256减持
20EYPTEYEPOINT INC$18.4M1.89%1.3M减持
21THCTENET HEALTHCARE CORP$18.2M1.86%97,280增持
22LIVNLIVANOVA PLC$17.3M1.77%210,529减持
23ANIPANI PHARMACEUTICALS INC$16.8M1.72%202,907减持
24BCRXBIOCRYST PHARMACEUTICALS INC$16.2M1.66%1.6M减持
25ALNYALNYLAM PHARMACEUTICALS INC$15.3M1.56%50,672增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR